Delivery Order SPE2DB22D2206-SPE2DB24FFD57
Award Date 1/18/24
Potential Completion Date 2/8/24
Potential Value $92K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $109,309.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order was placed under a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical. The contract has a performance location of...
- The Defense Logistics Agency (DLA) awarded a $75,998.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and is scheduled for completion by November 19, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $112,653.60 delivery order has a completion date of May 25, 2023 and was awarded on May 4, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical product Ocrevus. The $131,171.40 award has an August 18, 2022 completion date and was made on July 28, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced government contractor that has received numerous DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML vials. The $109,309.50 award has an April 7, 2022 completion date and was issued on March 17, 2022. AmerisourceBergen, a large pharmaceutical distributor, has previously received numerous DLA delivery orders to supply pharmaceuticals, medical supplies, and distribution services in...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The $124,402.96 contract is for supplies to be delivered by March 14, 2023. AmerisourceBergen Drug Corp, as the prime contractor, will fulfill this order from its corporate office located in Conshohocken, Pennsylvania. No set-aside designation was used...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of the pharmaceutical product Ocrevus 300 mg/10 ml vial, with a completion date of February 26, 2024 and a potential value of $46,236.16. Amerisourcebergen Drug Corp, as the prime contractor, will supply this...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...
- Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $23,118.08. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical and medical supplies in...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $115,590.40 contract is for the supply of OCREVUS 300 mg/10 ml vials to support military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor and has been awarded multiple previous contracts by DLA to provide pharmaceuticals and medical supplies to the Department of Defense. This delivery order...